<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Guarnerio J</submitter><funding>U.S. Department of Health &amp;amp; Human Services | NIH | National Cancer Institute</funding><funding>NCI NIH HHS</funding><funding>Novo Nordisk Fonden</funding><funding>NIH HHS</funding><pagination>628-640</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC6796857</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>29(8)</volume><pubmed_abstract>circRNAs arise from back splicing events during mRNA processing, and when deregulated can play an active role in cancer. Here we characterize a new circRNA (circPOK) encoded by the Zbtb7a gene (also kown as POKEMON, LRF) in the context of mesenchymal tumor progression. circPOK functions as a non-coding proto-oncogenic RNA independently and antithetically to its linear transcript counterpart, which acts as a tumor suppressor by encoding the Pokemon transcription factor. We find that circPOK regulates pro-proliferative and pro-angiogenic factors by co-activation of the ILF2/3 complex. Importantly, the expression of Pokemon protein and circRNA is aberrantly uncoupled in cancer through differential post-transcriptional regulation. Thus, we identify a novel type of genetic unit, the iRegulon, t</pubmed_abstract><journal>Cell research</journal><pubmed_title>Intragenic antagonistic roles of protein and circRNA in tumorigenesis.</pubmed_title><pmcid>PMC6796857</pmcid><funding_grant_id>R00 CA212200</funding_grant_id><funding_grant_id>R35 CA197529</funding_grant_id><funding_grant_id>DP5 OD012160</funding_grant_id><funding_grant_id>NNF16SA0023584</funding_grant_id><funding_grant_id>R01 CA178908</funding_grant_id><funding_grant_id>K99 CA212200</funding_grant_id><pubmed_authors>Kauppinen S</pubmed_authors><pubmed_authors>Nielsen GP</pubmed_authors><pubmed_authors>Panella R</pubmed_authors><pubmed_authors>Mae Katon J</pubmed_authors><pubmed_authors>Cordon-Cardo C</pubmed_authors><pubmed_authors>Pandolfi PP</pubmed_authors><pubmed_authors>Papa A</pubmed_authors><pubmed_authors>Batish M</pubmed_authors><pubmed_authors>Deshpande V</pubmed_authors><pubmed_authors>Matsumoto A</pubmed_authors><pubmed_authors>Petri A</pubmed_authors><pubmed_authors>Dimitrios S</pubmed_authors><pubmed_authors>Zhang Y</pubmed_authors><pubmed_authors>Cheloni G</pubmed_authors><pubmed_authors>Castillo-Martin M</pubmed_authors><pubmed_authors>Loretelli C</pubmed_authors><pubmed_authors>Garbutt C</pubmed_authors><pubmed_authors>Simpson M</pubmed_authors><pubmed_authors>Clohessy JG</pubmed_authors><pubmed_authors>Guarnerio J</pubmed_authors></additional><is_claimable>false</is_claimable><name>Intragenic antagonistic roles of protein and circRNA in tumorigenesis.</name><description>circRNAs arise from back splicing events during mRNA processing, and when deregulated can play an active role in cancer. Here we characterize a new circRNA (circPOK) encoded by the Zbtb7a gene (also kown as POKEMON, LRF) in the context of mesenchymal tumor progression. circPOK functions as a non-coding proto-oncogenic RNA independently and antithetically to its linear transcript counterpart, which acts as a tumor suppressor by encoding the Pokemon transcription factor. We find that circPOK regulates pro-proliferative and pro-angiogenic factors by co-activation of the ILF2/3 complex. Importantly, the expression of Pokemon protein and circRNA is aberrantly uncoupled in cancer through differential post-transcriptional regulation. Thus, we identify a novel type of genetic unit, the iRegulon, t</description><dates><release>2019-01-01T00:00:00Z</release><publication>2019 Aug</publication><modification>2025-04-19T04:30:57.636Z</modification><creation>2025-04-19T04:30:57.636Z</creation></dates><accession>S-EPMC6796857</accession><cross_references><pubmed>31209250</pubmed><doi>10.1038/s41422-019-0192-1</doi></cross_references></HashMap>